Yohei Misumi

Progressive leptomeningeal involvement on gadolinium-enhanced FLAIR MRI in hereditary transthyretin amyloidosis with the V30M (p.V50M) mutation.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 17, 2026

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 29, 2026

Idiopathic Multicentric Castleman Disease Presenting as Recurrent Acute-Onset Demyelinating Neuropathy.

Journal: Internal medicine (Tokyo, Japan)

Published: May 31, 2026

Cleidocranial dysplasia caused by a novel de novo RUNX2 splice-site variant.

Journal: Human genome variation

Published: April 21, 2026

Development and validation of the modified-comprehensive Kumamoto Score: a multi-organ assessment tool for hereditary transthyretin amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: April 01, 2026

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: February 16, 2026

Long-term outcome of acquired transthyretin amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: January 06, 2026

Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A.

Journal: Neurology and therapy

Published: December 05, 2025

High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort study.

Journal: Journal of neurology

Published: November 13, 2025

Progressive leptomeningeal involvement on gadolinium-enhanced FLAIR MRI in hereditary transthyretin amyloidosis with the V30M (p.V50M) mutation.

Progressive leptomeningeal involvement on gadolinium-enhanced FLAIR MRI in hereditary transthyretin amyloidosis with the V30M (p.V50M) mutation.

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

Idiopathic Multicentric Castleman Disease Presenting as Recurrent Acute-Onset Demyelinating Neuropathy.

Idiopathic Multicentric Castleman Disease Presenting as Recurrent Acute-Onset Demyelinating Neuropathy.

Cleidocranial dysplasia caused by a novel de novo RUNX2 splice-site variant.

Cleidocranial dysplasia caused by a novel de novo RUNX2 splice-site variant.

Development and validation of the modified-comprehensive Kumamoto Score: a multi-organ assessment tool for hereditary transthyretin amyloidosis.

Development and validation of the modified-comprehensive Kumamoto Score: a multi-organ assessment tool for hereditary transthyretin amyloidosis.

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.

Long-term outcome of acquired transthyretin amyloidosis.

Long-term outcome of acquired transthyretin amyloidosis.

Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A.

Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A.

High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort study.

High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort study.

Clinical features of chronic inflammatory demyelinating polyneuropathy: a single-center experience with 33 patients.

Clinical features of chronic inflammatory demyelinating polyneuropathy: a single-center experience with 33 patients.

Non-pterygium Escobar syndrome from compound-heterozygous CHRNG variants: genotype-phenotype insights.

Non-pterygium Escobar syndrome from compound-heterozygous CHRNG variants: genotype-phenotype insights.

ZMYND11 p.Arg600Trp variant associated with a distinctive neurodevelopmental phenotype.

ZMYND11 p.Arg600Trp variant associated with a distinctive neurodevelopmental phenotype.